Hydroxycarbamide in very young children with sickle-cell anaemia: A multicentre, randomised, controlled trial (BABY HUG)

The Lancet

Volumn 377, Issue 9778, 2011, Pages 1663-1672

  Wang, Winfred C ^a   Ware, Russell E ^a   Miller, Scott T ^b   Iyer, Rathi V ^c   Casella, James F ^d   Minniti, Caterina P ^e   Rana, Sohail ^f   Thornburg, Courtney D ^g   Rogers, Zora R ^h   Kalpatthi, Ram V ⁱ   Barredo, Julio C ^j   Brown, R Clark ^k   Sarnaik, Sharada A ^l   Howard, Thomas H ^m   Wynn, Lynn W ^a   Kutlar, Abdullah ⁿ   Armstrong, F Daniel ^j   Files, Beatrice A ^k   Goldsmith, Jonathan C ^o   Waclawiw, Myron A ^o   Huang, Xiangke ^p   Thompson, Bruce W ^p   more..

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^b SUNY DOWNSTATE MEDICAL CENTER   (United States)

^c UNIVERSITY OF MISSISSIPPI   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^f HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^g DUKE UNIVERSITY   (United States)

^h UNIVERSITY OF TEXAS AT DALLAS   (United States)

ⁱ MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^j UNIVERSITY OF MIAMI   (United States)

^k EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^l CHILDREN'S HOSPITAL OF MICHIGAN   (United States)

^m UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

ⁿ MEDICAL COLLEGE OF GEORGIA   (United States)

^o NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^p Clinical Trials & Surveys Corp   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HEMOGLOBIN F; HEMOGLOBIN S; HYDROXYUREA; PENTETATE TECHNETIUM TC 99M; PLACEBO;

ACUTE CHEST SYNDROME; ARTICLE; BACTEREMIA; BLOOD CELL COUNT; CAREGIVER; CHILD; CHILD CARE; CHILD HEALTH; CONTROLLED STUDY; DACTYLITIS; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG FATALITY; DRUG FORMULATION; DRUG SAFETY; FEMALE; FUNDING; GASTROENTERITIS; GLOMERULUS FILTRATION RATE; HEMOGLOBIN BLOOD LEVEL; HOSPITALIZATION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; MUTAGENICITY; NERVE CELL DIFFERENTIATION; NEUTROPENIA; PAIN; PRIAPISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEPSIS; SICKLE CELL ANEMIA; SICKLE CELL BETA THALASSEMIA; SPLEEN FUNCTION; SPLENOMEGALY; STROKE;

EID: 79955909191     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(11)60355-3     Document Type: Article

References (30)

1. OS Platt, BD Thorington, DJ Brambilla Pain in sickle cell disease. Rates and risk factors N Engl J Med 325 1991 11 16
2. Platt OS, Brambilla DJ, Rosse WF, et al. Mortality in sickle cell disease. Life expectancy and risk factors for early death. N Engl J Med 1994; 330: 1639-44.
3. RE Ware How I use hydroxyurea to treat young patients with sickle cell anemia Blood 115 2010 5300 5311
4. S Charache, ML Terrin, RD Moore Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia N Engl J Med 332 1995 1317 1322
5. A Ferster, C Vermylen, G Cornu Hydroxyurea for treatment of severe sickle cell anemia: a pediatric clinical trial Blood 88 1996 1960 1964 (Pubitemid 26307897)
6. WC Wang, LW Wynn, ZR Rogers, JP Scott, PA Lane, RE Ware A two-year pilot trial of hydroxyurea in very young children with sickle-cell anemia J Pediatr 139 2001 790 796 (Pubitemid 34014457)
7. DR Wigfall, RE Ware, MR Burchinal, TR Kinney, JW Foreman Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease J Pediatr 136 2000 749 753 (Pubitemid 30415648)
8. BW Thompson, ST Miller, ZR Rogers The pediatric hydroxyurea phase III clinical trial (BABY HUG): challenges of study design Pediatr Blood Cancer 54 2010 250 255
9. MM Heeney, MR Whorton, TA Howard, CA Johnson, RE Ware Chemical and functional analysis of hydroxyurea oral solutions J Pediatr Hematol Oncol 26 2004 179 184 (Pubitemid 38314597)
10. RE Ware, RC Rees, SA Sarnaik Renal function in infants with sickle cell anemia: baseline data from the BABY HUG trial J Pediatr 156 2010 66 70
11. ZR Rogers, WC Wang, Z Luo Biomarkers of splenic function in infants with sickle cell anemia: baseline data from the BABY HUG trial Blood 117 2011 2614 2617
12. ST Miller, WC Wang, R Iyer Urine concentrating ability in infants with sickle cell disease: baseline data from the phase III trial of hydroxyurea (BABY HUG) Pediatr Blood Cancer 54 2010 265 268
13. VN Hanft, SR Fruchtman, CV Pickens, WF Rosse, TA Howard, RE Ware Acquired DNA mutations associated with in vivo hydroxyurea exposure Blood 95 2000 3589 3593 (Pubitemid 30428496)
14. JM Flanagan, TA Howard, N Mortier Assessment of genotoxicity associated with hydroxyurea therapy in children with sickle cell anemia Mutat Res 698 2010 38 42
15. PK Andersen, RD Gill Cox's regression model for counting processes: a large sample study Ann Statist 10 1982 1100 1120
16. S Lanzkron, JJ Strouse, R Wilson Systematic review: hydroxyurea for the treatment of adults with sickle cell disease Ann Intern Med 148 2008 939 955 (Pubitemid 351860826)
17. JJ Strouse, S Lanzkron, MC Beach Hydroxyurea for sickle cell disease: a systematic review for efficacy and toxicity in children Pediatrics 122 2008 1332 1342
18. AP Jones, SC Davies, A Olujohungbe Hydroxyurea for sickle cell disease (Review) The Cochrane Library 1 2009 1 62
19. A Santos, V Pinheiro, C Anjos Scintigraphic follow-up of the effects of hydroxyurea on splenic function in patients with sickle cell disease Eur J Nucl Med Mol Imaging 29 2002 536 541
20. JS Hankins, KJ Helton, MB McCarville Preservation of spleen and brain function in children with sickle cell anemia treated with hydroxyurea Pediatr Blood Cancer 50 2008 293 297
21. NF Olivieri, EP Vichinsky Hydroxyurea in children with sickle cell disease: impact on splenic function and compliance with therapy J Pediatr Hematol Oncol 20 1998 26 31 (Pubitemid 28119752)
22. CD Fitzhugh, DR Wigfall, RE Ware Enalapril and hydroxyurea therapy for children with sickle nephropathy Pediatr Blood Cancer 45 2005 982 985 (Pubitemid 41552170)
23. CD Thornburg, N Dixon, S Burgett A pilot study of hydroxyurea to prevent chronic organ damage in young children with sickle cell anemia Pediatr Blood Cancer 52 2009 609 615
24. SA Zimmerman, WH Schultz, JS Davis Sustained long-term hematologic efficacy of hydroxyurea at maximum tolerated dose in children with sickle cell disease Blood 103 2004 2039 2045 (Pubitemid 38326218)
25. ST Miller, LA Sleeper, CH Pegelow Predicting adverse outcomes in children with sickle cell disease: a report from the Cooperative Study (CSSCD) N Engl J Med 342 2000 83 89 (Pubitemid 30036599)
26. CT Quinn, NJ Lee, EP Shull Prediction of adverse outcomes in children with sickle cell anemia: a study of the Dallas Newborn Cohort Blood 111 2008 544 548
27. MH Steinberg, WF McCarthy, O Castro The risks and benefits of long-term use of hydroxyurea in sickle cell anemia: a 17.5 year follow-up Am J Hematol 85 2010 403 408
28. E Voskaridou, D Christoulas, A Bilalis The effect of prolonged administration of hydroxyurea on morbidity and mortality in adult patients with sickle cell syndromes: results of a 17-year, single-center trial (LaSHS) Blood 115 2010 2354 2363
29. JS Hankins, RE Ware, ZR Rogers Long-term hydroxyurea therapy for infants with sickle cell anemia - the HUSOFT extension study Blood 106 2005 2264 2275
30. OW Brawley, LJ Cornelius, LR Edwards National Institutes of Health Consensus Development Conference statement: hydroxyurea treatment for sickle cell disease Ann Intern Med 148 2008 932 938 (Pubitemid 351860825)